Clinical implication of PSA bounce after treatment of prostate cancer with brachytherapy and/or external beam radiotherapy with or without androgen deprivation

被引：1
|
作者：
Antonucci, JV [1 ]
Fitch, DL [1 ]
Vargas, CE [1 ]
Boike, T [1 ]
Byrd, C [1 ]
Gustafson, GS [1 ]
Martinez, AA [1 ]
Vicini, FA [1 ]
Kestin, LL [1 ]
机构：
[1] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48072 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2122
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [31] PSA Kinetics: HDR prostate brachytherapy boost in combination with external beam radiotherapy
    Rodda, S.
    Sun, F.
    Henry, A.
    Franks, K.
    Bottomley, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S625 - S625
  • [32] Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
    Yamada, Yasuhiro
    Okihara, Koji
    Iwata, Tsuyoshi
    Masui, Koji
    Kamoi, Kazumi
    Yamada, Kei
    Miki, Tsuneharu
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (06) : 899 - 903
  • [33] Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
    Burchardt, Wojciech
    Skowronek, Janusz
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2018, 10 (01) : 1 - 9
  • [34] Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage treatment for patients with locally recurrent prostate cancer after external beam irradiation
    Wong, W
    Buskirk, S
    Schild, S
    Prussak, K
    Davis, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S302 - S303
  • [35] Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer
    Dosoretz, Arie P.
    Yu, James B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : 1718 - +
  • [36] Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation
    Geara, Fady B.
    Bulbul, Muhammad
    Khauli, Raja B.
    Andraos, Therese Y.
    Abboud, Mirna
    Al Mousa, Abdelatif
    Sarhan, Nasim
    Salem, Ahmed
    Ghatasheh, Hamza
    Alnsour, Anoud
    Ayoub, Zeina
    Abu Gheida, Ibrahim
    Charafeddine, Maya
    Shahait, Mohammed
    Shamseddine, Ali
    Abu Gheida, Rami
    Khader, Jamal
    RADIATION ONCOLOGY, 2017, 12
  • [37] Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation
    Fady B. Geara
    Muhammad Bulbul
    Raja B. Khauli
    Therese Y. Andraos
    Mirna Abboud
    Abdelatif Al Mousa
    Nasim Sarhan
    Ahmed Salem
    Hamza Ghatasheh
    Anoud Alnsour
    Zeina Ayoub
    Ibrahim Abu Gheida
    Maya Charafeddine
    Mohammed Shahait
    Ali Shamseddine
    Rami Abu Gheida
    Jamal Khader
    Radiation Oncology, 12
  • [38] HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for unfavourable stage prostate cancer
    Kurek, R
    Martin, T
    Röddiger, S
    Dannenberg, T
    Rogge, B
    Baltas, D
    Tunn, U
    Zamboglou, N
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S94 - S94
  • [39] HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for unfavorable stage prostate cancer
    Kurek, R
    Martin, T
    Roeddiger, S
    Dannenberg, T
    Rogge, B
    Baltas, D
    Tunn, UW
    Zamboglou, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 4 - 4
  • [40] HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for unfavorable stage prostate cancer
    Kurek, R
    Martin, T
    Röddiger, S
    Dannenberg, T
    Rogge, B
    Baltas, D
    Tunn, UW
    Zamboglou, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 115 - 115
12345